AGIO:NASDAQ
Agios Pharmaceuticals Inc
29,58 USD
arrow_downward
-1,87%(-0,57) 1D
17-ноя., 10:28:06 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
30,09 USD
High
30,38 USD
Low
29,40 USD
Mkt. cap
1,77 млд
Avg. vol.
1,23 млн
Volume
56,14 миң
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
Open
30,09 USD
High
30,38 USD
Low
29,40 USD
Mkt. cap
1,77 млд
Avg. vol.
1,23 млн
Volume
56,14 миң
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
News stories
From web sources and news partners
TradingView
·
1 саат мурун
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Trade Mixed Ahead of Nvidia’s Q3 Earnings— CBRS, AMZN, RCAT in Focus (UPDATED)
The Motley Fool
·
1 саат мурун
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
Coinpaper
·
29 мүнөт мурун
Stock Market Today: S&P 500 Struggles Ahead of Nvidia Earnings After $2 Trillion Stock Rout
The Defiant
·
14 саат мурун
Ondo Launches S&P 500 Portfolio Token With Loss Buffers
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc